Pharmacokinetic Characterization of the DDAH1 Inhibitors ZST316 and ZST152 in Mice Using a HPLC-MS/MS Method
The pharmacokinetic profile of ZST316 and ZST152, arginine analogues with inhibitory activity towards human dimethylarginine dimethylaminohydrolase-1 (DDAH1), was investigated in mice using a newly developed HPLC-MS/MS method. The method proved to be reproducible, precise, and accurate for the measu...
Main Authors: | Arduino A. Mangoni, Tommaso Ceruti, Roberta Frapolli, Massimo Russo, Stefania Fichera, Massimo Zucchetti, Sara Tommasi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2022-02-01
|
Series: | Molecules |
Subjects: | |
Online Access: | https://www.mdpi.com/1420-3049/27/3/1017 |
Similar Items
-
Development of a HPLC-MS/MS Method to Assess the Pharmacokinetics and Tumour Distribution of the Dimethylarginine Dimethylaminohydrolase 1 Inhibitors ZST316 and L-257 in a Xenograft Model of Triple-Negative Breast Cancer in Mice
by: Tommaso Ceruti, et al.
Published: (2023-12-01) -
Inhibitors of the Hydrolytic Enzyme Dimethylarginine Dimethylaminohydrolase (DDAH): Discovery, Synthesis and Development
by: Rhys B. Murphy, et al.
Published: (2016-05-01) -
The effect of haptoglobin genotype on the association of asymmetric dimethylarginine and DDAH 1 polymorphism with diabetic macroangiopathy
by: Shiyun Wang, et al.
Published: (2022-12-01) -
Influencia del nivel de deformación previa en el comportamiento a fatiga de metales dúctiles para embutición
by: Gómez, C., et al.
Published: (2004-04-01) -
Asymmetric Dimethylarginine: Clinical Applications in Pediatric Medicine
by: You-Lin Tain, et al.
Published: (2011-02-01)